Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Scinopharm Taiwan's dividends per share for the
three
months ended in Mar. 2026 was NT$0.00. Its dividends per share for the trailing twelve months (TTM) ended in Mar. 2026 was NT$0.35. Its Dividend Payout Ratio for the
three
months ended in Mar. 2026 was 0.00. As of today, Scinopharm Taiwan's Dividend Yield % is 1.45%.
Warning Sign:
If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Scinopharm Taiwan Ltd is 2.36, which seems too high.
Warning Sign:
Scinopharm Taiwan Ltd stock Dividend Yield % is close to 1-year low.
During the past 12 months, Scinopharm Taiwan's average Dividends Per Share Growth Rate was 16.70% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was -10.00% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was -1.50% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 4.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Scinopharm Taiwan was 131.00% per year. The lowest was -38.80% per year. And the median was -1.40% per year.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Scinopharm Taiwan (TPE:1789) Dividends per Share Explanation
1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.
Scinopharm Taiwan's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as
During the past 13 years, the highest Dividend Payout Ratio of Scinopharm Taiwan was 2.36. The lowest was 0.32. And the median was 0.93.
Warning Sign:
If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Scinopharm Taiwan Ltd is 2.36, which seems too high.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
Scinopharm Taiwan Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
TWD 0.290000
2026-07-02
2026-07-03
2026-07-27
Cash Dividend
annually
TWD:TWD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Scinopharm Taiwan's Dividend Yield (%) for Today is calculated as
Current Share Price is NT$20.05.
Scinopharm Taiwan's Dividends per Share for the trailing twelve months (TTM) ended in Today is NT$0.29.
During the past 13 years, the highest Dividend Yield of Scinopharm Taiwan was 4.05%. The lowest was 0.42%. And the median was 1.42%.
Warning Sign:
Scinopharm Taiwan Ltd stock Dividend Yield % is close to 1-year low.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Scinopharm Taiwan Dividends per Share Related Terms
Scinopharm Taiwan Dividends per Share Historical Data
* Premium members only.
The historical data trend for Scinopharm Taiwan's Dividends per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:1789 vs ZTS, UTHR: Dividends per Share Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Scinopharm Taiwan's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Scinopharm Taiwan Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Scinopharm Taiwan's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Scinopharm Taiwan's Dividend Yield % falls into.
Scinopharm Taiwan (TPE:1789) has a Dividends per Share of NT$0.35 as of Mar. 2026. Dividends per share represents the per-share amount paid as dividends. View historical data on Scinopharm Taiwan and its competitors.
Is Scinopharm Taiwan's Dividends per Share too high?
Scinopharm Taiwan's current Dividends per Share is NT$0.35. Overall, Scinopharm Taiwan has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Scinopharm Taiwan's Dividends per Share compare to ZTS and UTHR?
Scinopharm Taiwan's Dividends per Share of NT$0.35 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends per Share for a Drug Manufacturers company?
A good Dividends per Share depends on the Drug Manufacturers industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends per Share mean?
A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on Scinopharm Taiwan and its competitors. Scinopharm Taiwan's current Dividends per Share is NT$0.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scinopharm Taiwan stock overvalued right now?
Based on GuruFocus' analysis, Scinopharm Taiwan (TPE:1789) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$24.82, compared to a current price of NT$20.05 — trading 19.2% below its estimated fair value. The current Dividends per Share is NT$0.35. Scinopharm Taiwan's overall GF Score™ is 74/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends per Share calculated?
Dividends per Share is calculated from a company's financial statements. For Scinopharm Taiwan (TPE:1789), the current Dividends per Share is NT$0.35 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Scinopharm Taiwan (TPE:1789) Overvalued in 2026?
Based on GuruFocus' analysis, Scinopharm Taiwan stock appears to be undervalued.
The current stock price of NT$20.05 is trading 19.2% below its estimated GF Value™ of NT$24.82.
GuruFocus considers Scinopharm Taiwan to be Modestly Undervalued.
Key valuation signals for TPE:1789:
Dividends per Share: NT$0.35
GF Value™: NT$24.82 vs. price of NT$20.05 (19.2% below fair value)
No single metric tells the full story. See the TPE:1789 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Scinopharm Taiwan Ltd is mainly engaged in the manufacture of western medicines and other chemical materials, biological technology services, intellectual property rights, international trade, and the research, development, production, manufacture, and sales of Active Pharmaceutical Ingredients (API), albumin medicines, oligonucleotide medicines, peptide medicines, injections, and new small molecule drugs. The Company also provides related consulting and technical services and international trade for the above products. In addition, the Company sells chemical material reprocessed from material recycled from the Company's manufacturing process.
74GF Score
Get the complete analysis for TPE:1789
Dividends per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1789 has been successfully added to your 
